GAMMA Investing »

Acelyrin shares owned by GAMMA Investing

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.6k 678 6.75
2023-12-31 $1.3k 174 7.62

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
BlackRock
Opaleye Management
OrbiMed Advisors
venBio Partners
Artal Group
Jpmorgan Chase & Co
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management

View all funds holding Acelyrin